Minimal chemical modification enables alpha/beta radiolabeling of sacituzumab govitecan for targeted therapy in high grade serous ovarian cancer.
Saved in:
| Title: | Minimal chemical modification enables alpha/beta radiolabeling of sacituzumab govitecan for targeted therapy in high grade serous ovarian cancer. |
|---|---|
| Authors: | Loor A; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mack KN; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pharmacology, Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY, USA., Bauer D; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ingham A; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Pratt EC; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. edwin.pratt@stonybrookmedicine.edu.; Stony Brook University Cancer Center, Stony Brook, NY, USA. edwin.pratt@stonybrookmedicine.edu., Lewis JS; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. lewisj2@mskcc.org.; Department of Pharmacology, Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY, USA. lewisj2@mskcc.org.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. lewisj2@mskcc.org. |
| Source: | European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2026 Jun; Vol. 53 (7), pp. 4587-4596. Date of Electronic Publication: 2026 Feb 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
